Thrombin generation assay and other universal tests for monitoring haemophilia therapy

Haemophilia, Supplement

Volumn 10, Issue 2, 2004, Pages 17-21

  Varadi K ^a   Turecek, Peter L ^a   Schwarz, H P ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

Factor VIII; FEIBA ; Inhibitor; Thrombin generation

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 ANTIBODY; THROMBIN;

ANTIBODY TITER; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG MONITORING; FIBRINOLYSIS; HEMOPHILIA; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBIN TIME; THROMBOELASTOGRAPHY;

EID: 11044227414     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.00936.x     Document Type: Article

References (20)

1. Lusher JM. Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors: benefits and limitations. Semin Hematol 1994; 31 (2 (Suppl. 4): 49-52.
2. Roberts HR. The use of agents that by-pass factor VIII inhibitors in patients with Haemophilia. Vox Sang 1999; 77 (Suppl. 1): 38-41.
3. Turecek PL, Váradi K, Gritsch H et al. Factor Xa and prothrombin: mechanism of action of FEIBA. Vox Sang 1999; 77 (Suppl. 1): 72-9.
4. ten Cate H, Bauer KA, Levi M et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993; 92: 1207-12.
5. Monroe DM, Hoffman M, Oliver JA, Roberts HR. A possible mechanism of activated factor VIIa independent of tissue factor. Blood Coagul Fibrinolysis 1998; 9 (Suppl. 1): S15-S20.
6. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenscgr 1948; 26: 577-83.
7. Macfarlane RG, Biggs R. A thrombin genenration test. the application in haemophilia and thrombocytopenia. J Clin Pathol 1953; 6: 3-8.
8. Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17.
9. Schwarz HP, Rengs H, Elsinger F. An assay for the bioavailability of FEIBA. Abstract at the Kyoto Satellite Symposia of the XIIth ISTH-Congress, Kyoto, 27-28 August 1989.
10. Gill C, Schwarz HP, Wentz MA, Montgomery RR. Platelet prothrombinase activity may predict successful activated prothrombin complex concentrate (FEIBA) treatment. Blood 1990; 76 (Suppl. 1): 399a.
11. Sultan Y, Loyer F. In vitro evaluation of factor VIII-bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: Thrombin generation test in the presence of collagen-activated platelets. J Lab Clin Med 1993; 121: 444-52.
12. Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74: 134-8.
13. Hemker HC, Giesen P, Al Dieri R et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
14. Turecek PL, Váradi K, Keil B et al. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb 2003; 33: 16-22.
15. Wenker O, Wojciechowski Z, Sheinbaum R, Zisman E. Thrombelastography. The Internet Journal of Anesthesiology 1997; 1: N3. Available at: http://www.ispub.com/journals/IJA/Vol1N3 /teg.htm. Published 1 July, 1997; last updated 28 January 1999.
16. Toh CH, Giles AR. Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation (DIC). Clin Lab Haematol 2002; 24: 321-7.
17. Carr ME, Martin EJ, Kuhn JG, Spiess BD. Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT). J Thromb Haemost 2003; 1: 1977-83.
18. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-8.
19. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2 102-10.
20. Váradi, Negrier C, Bemtorp E et al. Monitoring the bioavailability of FEIBA with a thrombin generation assay. J Thromb Haemost 2003; 1: 2374-80.